| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Barrientos, C Marín, O Miró, J Casademont, M Gómez, V Nunes, E Tolosa, A Urbano-Márquez, F Cardellac. Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats. Journal of neuroscience research. vol 53. issue 4. 1998-10-28. PMID:9710267. |
the objectives of the current study were to evaluate (1) the respiratory rates and enzyme activities of brain and muscle mitochondria from rats chronically treated with haloperidol, (2) the protective role of dopamine (da) d-1 (skf38393) and d-2 (quinpirole) receptor agonists, and (3) the effect of haloperidol on the mitochondrial dna (mtdna) and protein synthesis. |
1998-10-28 |
2023-08-12 |
rat |
| Podolski IY. Possibility of "superfast" consolidation of long-term memory. Membrane & cell biology. vol 11. issue 6. 1998-10-27. PMID:9718571. |
it is shown that after one-trial learning of the motor skill (jumping out of the water), long-term memory traces are retained without forgetting and are resistant to the blockade of m-cholinoreceptors by scopolamine (2 mg/kg) and of d1/d2 dopamine receptors by haloperidol (10 mg/kg) as well as electroconvulsive shock applied tank wall, learning of necessary motor skills, automatization and minimization of the skilled movements in 1.5-3.0 min, after 5 to 7 trials at two-second intervals (superfast learning) is demonstrated. |
1998-10-27 |
2023-08-12 |
rat |
| M J O'Neill, C A Hicks, M A Ward, G P Cardwell, J M Reymann, H Allain, D Bentué-Ferre. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. European journal of pharmacology. vol 352. issue 1. 1998-10-26. PMID:9718265. |
to characterise the role played by dopamine receptors in ischaemic brain damage, we have evaluated the effects of pergolide, bromocriptine and lisuride (dopamine d2 receptor agonists), haloperidol (a dopamine d2 receptor antagonist), 2,3,4,5-tetrahydro-7,8,dihydroxy-1-phenyl-1h-3-benzazepine (skf 38393; a dopamine d1 receptor agonist) and (r)-(+)-8-chloro 2,3,4,5-tetra-hydro-3-methyl-5-phenyl-1h-3-benzazepin-7-ol (sch 23390; a dopamine d1 receptor antagonist) in the gerbil model of global cerebral ischaemia. |
1998-10-26 |
2023-08-12 |
Not clear |
| M J O'Neill, C A Hicks, M A Ward, G P Cardwell, J M Reymann, H Allain, D Bentué-Ferre. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. European journal of pharmacology. vol 352. issue 1. 1998-10-26. PMID:9718265. |
in contrast, the dopamine d2 receptor antagonist (haloperidol), the dopamine d1 receptor agonist (skf 38393) and the dopamine d1 receptor antagonist (sch 23390) failed to provide any neuroprotection in the model. |
1998-10-26 |
2023-08-12 |
Not clear |
| G Tanda, G Di Chiar. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. The European journal of neuroscience. vol 10. issue 3. 1998-10-22. PMID:9753186. |
systemic pretreatment with naloxonazine reduced or, depending on the dose, abolished, the stimulation of dopamine release in the nucleus accumbens shell by morphine, nicotine and ethanol, but did not affect that by haloperidol. |
1998-10-22 |
2023-08-12 |
rat |
| I Ushijima, Y Mizuki, M Suetsugi, T Akimoto, M Yamad. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration. Progress in neuro-psychopharmacology & biological psychiatry. vol 22. issue 4. 1998-10-13. PMID:9682282. |
in mice pretreated chronically with cocaine (indirect dopamine agonist: 10 mg/kg, s.c. on alternating days for 15 days), haloperidol (dopamine d2 antagonist: 0.3 mg/kg i.p.) |
1998-10-13 |
2023-08-12 |
mouse |
| I Ushijima, Y Mizuki, M Suetsugi, T Akimoto, M Yamad. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration. Progress in neuro-psychopharmacology & biological psychiatry. vol 22. issue 4. 1998-10-13. PMID:9682282. |
the results suggest that the coadministration of sch23390 with cocaine was able to block indirectly dopamine d2 receptor inhibition (subsensitivity) induced during the early withdrawal period from chronic cocaine, despite the fact that by itself sch23390 did not have an effect on haloperidol catalepsy. |
1998-10-13 |
2023-08-12 |
mouse |
| I Ushijima, Y Mizuki, M Suetsugi, T Akimoto, M Yamad. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration. Progress in neuro-psychopharmacology & biological psychiatry. vol 22. issue 4. 1998-10-13. PMID:9682282. |
these results also provide evidence that d2 receptor antagonists may be more effective as antipsychotic drugs than dopamine d1 receptor antagonist, since the coadministration of haloperidol with cocaine normalized the abnormal behaviors seen during early and long-term withdrawal periods from chronic cocaine. |
1998-10-13 |
2023-08-12 |
mouse |
| N I Dubrovina, R Y Il'yucheno. Contribution of presynaptic dopaminergic receptors to the mechanism of the reactivating effects of blockade of the GABA-benzodiazepine-ionophore complex. Neuroscience and behavioral physiology. vol 28. issue 3. 1998-10-05. PMID:9682234. |
changes in the reactivating efficiency of blockade of components of the gaba-benzodiazepine-ionophore complex were analyzed in conditions of preliminary activation and inhibition of dopamine autoreceptors using (+)zrrr and haloperidol respectively. |
1998-10-05 |
2023-08-12 |
mouse |
| T Watanabe, K Morimoto, M Nakamura, H Suwak. Modification of behavioral responses induced by electrical stimulation of the ventral tegmental area in rats. Behavioural brain research. vol 93. issue 1-2. 1998-09-24. PMID:9659994. |
the expression of behavioral responses to stimulation was significantly attenuated by dopamine (da) receptor or antagonists, such as haloperidol, ym-09151-2 and sch23390. |
1998-09-24 |
2023-08-12 |
rat |
| L Björklund, I Strömber. Dopaminergic growth patterns induced by striatal and cortical grafts show differences in sensitivity to increased striatal trophic activity induced by haloperidol. Journal of neuroscience research. vol 53. issue 2. 1998-09-24. PMID:9671973. |
chronic treatment with the dopamine antagonist haloperidol increase the neurotrophic activity in striatum, but it is not known how this trophic activity influences different patterns of dopaminergic growth. |
1998-09-24 |
2023-08-12 |
Not clear |
| M Cheido, G Idov. Neuropeptides in the immunomodulation: substance P-induced stimulation of immune response in mice. International journal of immunopharmacology. vol 19. issue 9-10. 1998-09-17. PMID:9637349. |
third, sp-induced immunostimulation was not observed after combination with the antagonist of the postsynaptic dopamine (da) d-2 receptors haloperidol (2 mg/kg) suggesting the involvement of the daergic system in the realization of this effect. |
1998-09-17 |
2023-08-12 |
mouse |
| S Samnick, S Ametamey, K L Leenders, P Vontobel, G Quack, C G Parsons, H Neu, P A Schubige. Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex. Nuclear medicine and biology. vol 25. issue 4. 1998-09-17. PMID:9639292. |
in a preliminary experiment, haloperidol, a dopamine d2 and sigma receptor antagonist, decreased the binding of 18f-mem from the brain regions examined, suggesting that binding was also occurring to the sigma recognition sites. |
1998-09-17 |
2023-08-12 |
mouse |
| J G Csernansky, M E Bardget. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophrenia bulletin. vol 24. issue 2. 1998-08-24. PMID:9613623. |
in animals, lesions of limbic-cortical neurons cause decreases in glutamatergic input to the nucleus accumbens and are also associated with decreases in presynaptic dopamine release, increases in the density of d2-like dopamine receptors, and insensitivity to the actions of dopamine antagonists such as haloperidol. |
1998-08-24 |
2023-08-12 |
Not clear |
| I P Lapi. [The pharmacological differences between kynurenine- and korazol-induced seizures (the participation of GABA-B receptors and dopamine)]. Eksperimental'naia i klinicheskaia farmakologiia. vol 61. issue 2. 1998-08-21. PMID:9621167. |
dopamine removed the effect of haloperidol. |
1998-08-21 |
2023-08-12 |
mouse |
| Y Minabe, E L Gardner, C R Ashb. Differential effects of chronic haloperidol administration on midbrain dopamine neurons in Sprague-Dawley, Fischer 344, and Lewis rats: an in vivo electrophysiological study. Synapse (New York, N.Y.). vol 29. issue 3. 1998-08-20. PMID:9635897. |
differential effects of chronic haloperidol administration on midbrain dopamine neurons in sprague-dawley, fischer 344, and lewis rats: an in vivo electrophysiological study. |
1998-08-20 |
2023-08-12 |
rat |
| S Monleón, C Vinader-Caerols, A Parr. Sex differences in escape-avoidance response in mice after acute administration of raclopride, clozapine, and SCH 23390. Pharmacology, biochemistry, and behavior. vol 60. issue 2. 1998-08-17. PMID:9632232. |
it is concluded that, besides haloperidol, other dopamine antagonists also show sex differences in their behavioral effects in escape-avoidance response in mice, with males being more affected than females by the inhibitory action of these drugs. |
1998-08-17 |
2023-08-12 |
mouse |
| S Dresel, K Tatsch, I Dähne, T Mager, J Scherer, K Hah. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 39. issue 7. 1998-08-11. PMID:9669383. |
the recently introduced neuroleptic, risperidone, was expected to block fewer dopamine d2 receptors than typical neuroleptics (e.g., haloperidol), but at comparable potency. |
1998-08-11 |
2023-08-12 |
Not clear |
| S Kasper, J Tauscher, B Küfferle, C Barnas, B Hesselmann, S Asenbaum, I Podreka, T Brück. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study. Psychopharmacology. vol 136. issue 4. 1998-08-07. PMID:9600582. |
sertindole and dopamine d2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123i-ibzm spect study. |
1998-08-07 |
2023-08-12 |
Not clear |
| E R Bongarzone, S G Howard, V Schonmann, A T Campagnon. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 18. issue 14. 1998-07-27. PMID:9651217. |
this effect was prevented by the dopamine antagonist haloperidol. |
1998-07-27 |
2023-08-12 |
Not clear |